IPR in healthcare has several different meanings depending on the context. The most common uses are Intellectual Property Rights (in pharmaceutical and health policy discussions), Inpatient Rehabilitation (in hospital and insurance settings), and Interproximal Reduction (in dentistry and orthodontics). You may also encounter it as Independent Professional Review in insurance or quality assurance contexts. Here’s what each one means and why it matters.
Intellectual Property Rights in Pharmaceuticals
In health policy, IPR almost always refers to intellectual property rights, the legal protections that give drug companies and medical device makers exclusive control over their inventions for a set period. These protections exist because developing a new drug can cost anywhere from $300 million to over $1 billion, and companies need a way to recoup those costs before competitors can copy their work.
The primary tool is a patent, which gives the inventor a monopoly on manufacturing and selling the product. Under the international TRIPS Agreement (administered by the World Trade Organization), patent protection lasts at least 20 years from the date a patent application is filed. In practice, much of that time gets consumed by clinical trials and regulatory approval, so the window of exclusive sales is shorter than 20 years. The patent holder can either sell the product directly or license the rights to another company.
This system creates a well-known tension in healthcare. Patents keep drug prices high during the exclusivity period, which limits access for patients and health systems with tight budgets. But without that financial incentive, fewer companies would invest in discovering new treatments. Governments sometimes step in with price controls, which can squeeze profit margins and push companies to find cheaper ways to develop and manufacture drugs.
IPR Waivers During Health Emergencies
The COVID-19 pandemic brought IPR debates into sharp focus. Multiple countries used a provision in the TRIPS Agreement (Article 31) to issue “compulsory licenses,” essentially overriding patents to allow local production of treatments like Remdesivir. Hungary, Russia, Israel, and Canada all took steps to bypass patent protections for pandemic-related drugs.
In 2020, India and South Africa proposed a broader waiver that would have suspended patent protections across diagnostics, therapeutics, and vaccines for COVID-19. After years of negotiation, the WTO adopted a narrower version in June 2022, limiting the waiver to COVID-19 vaccine production only. Eligible developing countries can use these flexibilities for five years. Separately, Moderna pledged not to enforce its mRNA vaccine patents during the pandemic, an unusual voluntary move.
Inpatient Rehabilitation Facilities
In hospital and insurance conversations, IPR typically refers to inpatient rehabilitation, sometimes written as IRF (inpatient rehabilitation facility). These are specialized hospital units or freestanding facilities designed for patients recovering from serious surgeries, severe injuries, or major medical events like strokes. The key distinction from other post-hospital care is intensity: inpatient rehab programs involve approximately three hours of therapy per day, five days per week, under direct physician supervision with coordinated care from multiple therapists and specialists.
Medicare covers inpatient rehabilitation when a doctor certifies that you need intensive rehabilitation therapy, continued medical supervision, and coordinated care that can’t be delivered in a less intensive setting. To maintain their status, these facilities must meet what’s known as the “60 percent rule,” meaning at least 60 percent of their patients must fall within specific diagnostic categories (such as stroke, spinal cord injury, or hip fracture) that require this level of care.
How IPR Differs From Skilled Nursing
The most common point of confusion is the difference between inpatient rehabilitation and a skilled nursing facility (SNF). A skilled nursing facility takes a more moderate approach, typically providing one to two hours of rehabilitation per day. It’s suited for patients who need ongoing medical care and some therapy but can’t handle or don’t require the intensity of an inpatient rehab program. Inpatient rehab is for patients who can actively participate in frequent, intensive therapy sessions and are expected to make significant functional gains in a relatively short time. If your doctor or case manager mentions IPR, they’re recommending the more intensive option.
Interproximal Reduction in Dentistry
In orthodontics, IPR stands for interproximal reduction, a procedure where your orthodontist carefully removes tiny amounts of enamel from the sides of your teeth to create small gaps. The goal is to make room for better alignment during treatment with braces or clear aligners, avoiding the need to extract a tooth entirely.
The amount removed is minimal, usually no more than half a millimeter per tooth. Your enamel is typically about 2.5 millimeters thick, so removing this small amount doesn’t compromise the structural integrity of the tooth. The procedure is done with a thin strip, disc, or bur, and most patients find it painless or only mildly uncomfortable. If your orthodontist recommends IPR as part of your treatment plan, it’s one of the most conservative ways to address crowding.
Independent Professional Review
The U.S. Department of Health and Human Services lists IPR as Independent Professional Review, a process used in insurance and quality assurance. In this context, an outside physician or clinical expert reviews a case to determine whether a proposed treatment is medically necessary, whether a claim denial was appropriate, or whether care met accepted standards. You’re most likely to encounter this if an insurance company denies a claim and you appeal the decision, triggering an independent review by someone not affiliated with your insurer.